サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1507997

動物用医薬品の世界市場の機会と2033年までの戦略

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 350 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
動物用医薬品の世界市場の機会と2033年までの戦略
出版日: 2024年07月04日
発行: The Business Research Company
ページ情報: 英文 350 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の動物用医薬品市場は2018年に232億9,310万米ドルと評価され、2023年までCAGR5.0％以上で成長しました。

ペット人口の増加

ペット人口の増加は、実績期間に動物用医薬品市場の成長を牽引しました。世界のペット人口の増加は、獣医の症例数の増加を意味します。世界の獣医社会は、ペット飼育の増加や動物福祉に配慮した診療の採用など、大きな変化を遂げつつあり、動物用医薬品の需要がさらに高まっています。例えば、2021年7月、米国を拠点とするコンサルティング業界のプラットフォームであるConsulting.USによると、米国におけるペットの犬と猫の数は、2019年の1億4,000万頭から2020年には1億4,900万頭に増加し、約7％の成長を示しています。また、米国の非営利団体である米国獣医師会によると、2020年には45％の世帯が犬を飼うようになり、2016年末の38％から増加しました。昨年の愛犬人口は8,370万～8,890万頭と推定され、2016年末から9%～16%増加しています。さらに、中国ペット産業協会によると、2021年、都市部におけるペットの犬と猫の数は2020年に1億80万匹を超え、2019年比で1.7％増加しました。2022年、アメリカ人はペットに1,368億米ドルを費やし、2021年（1,236億米ドル）から10.68％増加しました。したがって、ペット人口の増加が動物用医薬品市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

  • 動物用医薬品-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 動物用医薬品市場定義とセグメンテーション
  • 市場セグメンテーション：タイプ別
    • 獣医用ワクチン
    • 獣医用抗生物質
    • 獣医用寄生虫駆除剤
    • その他の動物用医薬品
  • 市場セグメンテーション：動物の種類別
    • 家畜
    • コンパニオンアニマル
  • 市場セグメンテーション：ワクチンの種類別
    • 不活化ワクチン
    • 弱毒化ワクチン
    • 組み換えワクチン
    • その他のワクチン
  • 市場セグメンテーション：投与経路別
    • 経口
    • 非経口
    • 外用薬
    • その他の投与経路
  • 市場セグメンテーション：エンドユーザー別
    • 動物病院
    • 獣医クリニック
    • 薬局とドラッグストア

第7章 主要な市場動向

  • 動物の治療における幹細胞療法への注目の高まり
  • 抗生物質耐性に対処するための獣医学におけるナノテクノロジーの応用
  • 動物の利便性向上を目的としたチュアブル錠の開発
  • 遠隔医療プラットフォームの活用による医療へのアクセス改善
  • 動物の疾病負担を軽減する先進ワクチンの開発
  • 寄生虫駆除に役立つスーパーコンボ駆虫剤の開発
  • サブユニットおよびウイルス様粒子（VLP）ベースのワクチンの使用
  • 市場企業間の戦略的パートナーシップとコラボレーション

第8章 動物用医薬品市場：マクロ経済シナリオ

  • COVID-19の影響：動物用医薬品市場
  • ウクライナ戦争の影響：動物用医薬品市場
  • 高インフレの影響：動物用医薬品市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因, 2018-2023
    • 市場抑制要因, 2018-2023
  • 市場成長予測, 2023-2028, 2033年
    • 市場促進要因, 2023-2028
    • 市場抑制要因, 2023-2028

第10章 世界の動物用医薬品市場：セグメンテーション

  • 世界の動物用医薬品市場：タイプ別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の動物用医薬品市場：動物の種類別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の動物用医薬品市場：ワクチンの種類別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の動物用医薬品市場：投与経路別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の動物用医薬品市場：エンドユーザー別、実績と予測, 2018-2023, 2028年, 2033年

第11章 動物用医薬品市場：地域・国別分析

  • 世界の動物用医薬品市場：地域別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の動物用医薬品市場：国別、実績と予測, 2018-2023, 2028年, 2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Zoetis Inc.
  • Ceva Sante Animale

第20章 その他の大手企業と革新的企業

  • Virbac SA
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Evonik Industries AG
  • Zydus Animal Health
  • Eco Animal Health
  • Animalcare Group
  • Neogen Corp
  • Phibro Animal Health
  • Mobedco-Vet
  • ImmuCell Corporation
  • Ourofino Saude Animal
  • Hipra
  • Biogenesis Bago
  • Huvepharma

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Phibro Animal Health Corporation Acquired Zoetis'
  • Merck Animal Health Acquired Elanco Animal Health's
  • EQT Acquired Dechra Pharmaceuticals
  • Wedgewood Pharmacy Merged With Blue Rabbit
  • Sun Pharmaceutical Acquired A Majority Stake In Vivaldis Health and Foods
  • Orion Corporation Acquired VMD NV
  • Zendal Group Acquired Maymo
  • Mitsui Acquired Sumitomo Pharma Animal Health
  • Zoetis Acquired Jurox
  • Vimian Group Acquired Heiland GmbH
  • Dechra Acquired Med-Pharmex
  • Bimeda Acquired Afrivet
  • Dechra Pharmaceuticals Acquired Piedmont Animal Health
  • Virbac Acquired Assets Of Elanco Animal Health Inc.
  • Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.

第24章 機会と戦略

  • 世界の動物用医薬品市場2028：新たな機会を提供する国
  • 世界の動物用医薬品市場2028：新たな機会を提供するセグメント
  • 世界の動物用医薬品市場2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 動物用医薬品市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1256

Veterinary pharmaceuticals or veterinary drugs are drugs that are intended for use in animals in the case of disease or illness. These products achieve their effect through pharmacological actions in the animal body.

The veterinary pharmaceuticals market consists of sales of veterinary pharmaceuticals by entities (organizations, sole traders and partnerships) that manufacture veterinary pharmaceuticals (or drugs) used to sedate, treat animal diseases and/or to improve animals' performance and health. The veterinary pharmaceuticals industry includes establishments that manufacture veterinary pharmaceuticals such as veterinary vaccines, veterinary antibiotics and other veterinary pharmaceuticals.

The global veterinary pharmaceuticals market was valued at $23,293.1 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.0%.

Increased Pet Population

The increase in the pet population drove the growth of the veterinary pharmaceuticals market during the historic period. A growing global pet population means an increase in veterinary caseloads. The global veterinary community is going through an enormous shift-change, with increasing pet ownership and the adoption of good animal welfare practices, thus further increasing demand for veterinary pharmaceuticals. For instance, in July 2021, according to Consulting.US, a US-based consulting industry platform, the number of pet dogs and cats in the USA increased from 140 million in 2019 to 149 million in 2020, representing approximately 7% growth. Also, in 2020, according to the American Veterinary Medical Association, a US-based not-for-profit organization, 45% of households owned dogs, up from 38% at year-end 2016. The population of pet dogs was estimated to be between 83.7 million and 88.9 million last year, up 9%-16% from year-end 2016. Furthermore, in 2021, according to the China Pet Industry Association, the number of pet dogs and cats in urban areas exceeded 100.8 million in 2020, 1.7 % up on 2019. In 2022, Americans spent $136.8 billion on their pets, up 10.68% from 2021 ($123.6 billion). Therefore, the increased pet population supported the growth of the veterinary pharmaceuticals market.

Increased Focus On Stem Cell Therapy To Treat Animals

Stem cell therapy is being increasingly adopted by veterinarians to treat orthopedic conditions such as osteoarthritis, ligament injuries and tendons in high commercial value species, such as racehorses. Stem cell therapy helps to restore motion and stimulate the regeneration of tendon, ligament and joint tissues by isolating adult stem cells from an animals' fat tissue and re-introducing these cells to reduce pain and inflammation. Some of the companies offering stem cell therapy in the USA include VetStem and MediVet. For instance, in April 2022, Boehringer Ingelheim, a German pharmaceutical company, launched RenuTend, a stem cell therapy for horses. It improves healing of tendon and suspensory ligament injuries. It is administered intralesionally, targeting fiber alignment and reducing scar tissue formation, enhancing the quality of healing.

The global veterinary pharmaceuticals market is highly concentrated, with a few large players operating in the market. The top ten competitors in the market made up 60.3% of the total market in 2022.

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for veterinary pharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The veterinary pharmaceuticals market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider veterinary pharmaceuticals market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by type of animal, by type of vaccine, by route of administration and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the veterinary pharmaceuticals market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by type of animal, by type of vaccine, by route of administration and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for veterinary pharmaceuticals providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Veterinary Vaccines; Veterinary Antibiotics; Veterinary Parasiticides; Other Veterinary Pharmaceuticals
  • 2) By Type Of Animal: Livestock Animals; Companion Animals
  • 3) By Type Of Vaccine: Inactivated Vaccines; Attenuated Vaccines; Recombinant Vaccines; Other Vaccines
  • 4) By Route Of Administration: Oral; Parenteral; Topical; Other Routes Of Administration
  • 5) By End-User: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores
  • Companies Mentioned: Merck & Co., Inc.; Boehringer Ingelheim International GmbH; Elanco Animal Health Incorporated; Zoetis Inc; Ceva Sante Animale
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Ontario; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; veterinary pharmaceuticals indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Veterinary Pharmaceuticals - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Veterinary Pharmaceuticals Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Veterinary Vaccines
    • 6.4.2 Veterinary Antibiotics
    • 6.4.3 Veterinary Parasiticides
    • 6.4.4 Other Veterinary Pharmaceuticals
  • 6.5 Market Segmentation By Type Of Animal
    • 6.5.1 Livestock Animals
    • 6.5.2 Companion Animals
  • 6.6 Market Segmentation By Type Of Vaccine
    • 6.6.1 Inactivated Vaccines
    • 6.6.2 Attenuated Vaccines
    • 6.6.3 Recombinant Vaccines
    • 6.6.4 Other Vaccines
  • 6.7 Market Segmentation By Route Of Administration
    • 6.7.1 Oral
    • 6.7.2 Parenteral
    • 6.7.3 Topical
    • 6.7.4 Other Routes Of Administration
  • 6.8 Market Segmentation By End-User
    • 6.8.1 Veterinary Hospitals
    • 6.8.2 Veterinary Clinics
    • 6.8.3 Pharmacies And Drug Stores

7 Major Market Trends

  • 7.1 Increased Focus On Stem Cell Therapy To Treat Animals
  • 7.2 Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
  • 7.3 Development Of Chewable Tablets To Improve Convenience In Animals
  • 7.4 Use Of Telemedicine Platforms To Improve Access To Care
  • 7.5 Development Of Advanced Vaccines To Reduce Disease Burden In Animals
  • 7.6 Development Of Super-Combo Parasiticides To Help Control Parasites
  • 7.7 Use Of Subunit And Virus-Like Particle (VLP)-Based Vaccines
  • 7.8 Strategic Partnerships And Collaborations Among Market Players

8 Veterinary Pharmaceuticals Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Veterinary Pharmaceuticals Market
  • 8.2 Impact Of The War In Ukraine On The Veterinary Pharmaceuticals Market
  • 8.3 Impact Of High Inflation On The Veterinary Pharmaceuticals Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018-2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Veterinary Pharmaceuticals Market Segmentation

  • 10.1 Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.5 Global Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Veterinary Pharmaceuticals Market, Regional and Country Analysis

  • 11.1 Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Veterinary Pharmaceuticals Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Veterinary Pharmaceuticals Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Summary
    • 15.12.1 Market Overview
    • 15.12.2 Country Information
    • 15.12.3 Market Information
    • 15.12.4 Background Information
    • 15.12.5 Government Initiatives
    • 15.12.6 Regulations
    • 15.12.7 Regulatory Bodies
    • 15.12.8 Major Associations
    • 15.12.9 Taxes Levied
    • 15.12.10 Corporate Tax Structure
    • 15.12.11 Investments
    • 15.12.12 Major Companies
  • 15.13 Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Ontario Market
  • 15.17 Ontario Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.18 Ontario Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.19 Ontario Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview 250
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Veterinary Pharmaceuticals Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Merck & Co., Inc.
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
    • 19.1.3 Business Strategy
    • 19.1.4 Financial Overview
  • 19.2 Boehringer Ingelheim International GmbH
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Elanco Animal Health Incorporated
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Zoetis Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Ceva Sante Animale
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Virbac SA
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Vetoquinol S.A.
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 Dechra Pharmaceuticals PLC
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Evonik Industries AG
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Zydus Animal Health
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Eco Animal Health
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 Animalcare Group
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Neogen Corp
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 Phibro Animal Health
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Mobedco-Vet
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 ImmuCell Corporation
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Ourofino Saude Animal
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Hipra
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Biogenesis Bago
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 Huvepharma
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Phibro Animal Health Corporation Acquired Zoetis'
  • 23.2 Merck Animal Health Acquired Elanco Animal Health's
  • 23.3 EQT Acquired Dechra Pharmaceuticals
  • 23.4 Wedgewood Pharmacy Merged With Blue Rabbit
  • 23.5 Sun Pharmaceutical Acquired A Majority Stake In Vivaldis Health and Foods
  • 23.6 Orion Corporation Acquired VMD NV
  • 23.7 Zendal Group Acquired Maymo
  • 23.8 Mitsui Acquired Sumitomo Pharma Animal Health
  • 23.9 Zoetis Acquired Jurox
  • 23.10 Vimian Group Acquired Heiland GmbH
  • 23.11 Dechra Acquired Med-Pharmex
  • 23.12 Bimeda Acquired Afrivet
  • 23.13 Dechra Pharmaceuticals Acquired Piedmont Animal Health
  • 23.14 Virbac Acquired Assets Of Elanco Animal Health Inc.
  • 23.15 Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.

24 Opportunities And Strategies

  • 24.1 Global Veterinary Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Veterinary Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Veterinary Pharmaceuticals Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Veterinary Pharmaceuticals Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer